Evaluation of the Murex HIV Ag/Ab Combination assay when used with dried blood spots

Clinical Microbiology and Infection

Volumn 13, Issue 11, 2007, Pages 1134-1136

  Lakshmi, V ^a   Sudha, T ^a   Bhanurekha, M ^a   Dandona, L ^b,c,d  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b George Institute for International Health India   (India)

^c Health Studies Area   (India)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dried blood spots; ELISA; Human immunodeficiency virus; Murex Ag Ab combination assay; p24 antigen; Surveillance

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MUREX;

EID: 35148833572     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01809.x     Document Type: Article

References (15)

1. Metcalf JA, Davey RT, Lane HC. Acquired immunodeficiency syndrome: serologic and virologic tests. In: Devita VT, Hellman S, Rosenberg SA, eds, AIDS. Biology, diagnosis, treatment and prevention, 4th edn. Philadelphia: Lippincott-Raven, 1997; 177-195.
2. Brust S, Duttmann H, Feldner J et al. Shortening of the diagnostic window with the new combined HIV p24 antigen and anti-HIV-1.2.O screening test. J Virol Methods 2000; 90: 153-165.
3. Gurtler L, Muhlbacher A, Michel U et al. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J Virol Methods 1998; 75: 27-38.
4. Ly TD, Martin L, Daghfal M et al. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: Evaluation of HIV seroconversion sensitivity and subtype detection. J Clin Microbiol 2001; 39: 3122-3128.
5. Weber B, Fall EMB, Berger A, Doerr HW. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol 1998; 36: 2235-2239.
6. Laperche S, Maniez-Montreuil M, Courouce AM. Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1. Transfus Clin Biol 2000; 7 (suppl 1): S18-S24.
7. Ly TD, Laperche S, Courouce AM. Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays. Eur J Clin Microbiol Infect Dis 2001; 20: 104-110.
8. Saville RD, Constantine NT, Cleghorn FR et al. Fourth generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody. J Clin Microbiol 2001; 39: 2518-2524.
9. Van Binsbergen J, Siebelink A, Jacobs A et al. Improved performance in seroconversion with a 4th generation HIV antigen-antibody assay. J Virol Methods 1999; 82: 77-84.
10. Ly TD, Edlinger C, Vabret A. Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing. J Clin Microbiol 2000; 38: 2459-2461.
11. Dandona L, Lakshmi V, Sudha T, Kumar GA, Dandona R. A population-based study of human immunodeficiency virus in south India reveals major differences from sentinel surveillance based estimates. BMC Med 2006; 4: 31.
12. Panteleeff DD, John G, Nduati R et al. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999; 37: 350-353.
13. Behets F, Kashamuka M, Pappaioanou M et al. Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol 1992; 30: 1179-1182.
14. Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet 1999; 353: 359-363.
15. Quinn TC, Brookmeyer R, Kline R et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000; 14: 2751-2757.